Grifols (GRFS) Shares Outstanding (Entity) (2009 - 2025)
Grifols (GRFS) Shares Outstanding (Entity) (2009 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.90 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | 680.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 680.51 Mn |
| Dec 31, 2024 | 679.67 Mn |
| Dec 31, 2023 | 679.76 Mn |
| Dec 31, 2022 | 679.81 Mn |
| Dec 31, 2021 | 681.56 Mn |
| Dec 31, 2020 | 685.52 Mn |
| Dec 31, 2019 | 685.12 Mn |
| Dec 31, 2018 | 684.71 Mn |
| Jun 30, 2018 | 86.93 Mn |
| Dec 31, 2017 | 684.20 Mn |
| Dec 31, 2016 | 683.23 Mn |
| Dec 31, 2015 | 683.55 Mn |
| Sep 30, 2015 | 126.63 Mn |
| Jun 30, 2015 | 126.63 Mn |
| Dec 31, 2014 | 685.34 Mn |
| Sep 30, 2014 | 85.23 Mn |
| Jun 30, 2014 | 85.23 Mn |
| Dec 31, 2013 | 681.01 Mn |
| Dec 31, 2012 | 685.40 Mn |
| Dec 31, 2011 | 616.07 Mn |